Individualized Management of Papillary Thyroid Microcarcinoma: Clinicopathological Risk Factors, Multifocality and Active Surveillance
Journal of Pioneering Medical Sciences · 05.07.2026 · 15 (6) · 132-137
DOI: 10.47310/jpms2026150617 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Pioneering Medical Sciences, online erschienen am 05.07.2026. Verfasst von Hayfa Abdullah Al-Olayan.
Abstract (Originalsprache)
Papillary Thyroid Microcarcinoma (PTMC), defined as papillary thyroid carcinoma ≤1 cm, accounts for an increasing share of thyroid cancer diagnoses worldwide. Although generally indolent, a subset exhibits aggressive clinicopathological features, including multifocality, extrathyroidal extension and lymph node metastasis, which complicate risk stratification and treatment. To summarize the current evidence regarding the prognostic significance of multifocality in PTMC, its underlying pathogenetic mechanisms and the evolving role of Active Surveillance (AS) versus surgical management.
Methods
This narrative review integrates epidemiological, molecular, guideline and outcome data to outline a risk-adapted approach. Evidence was identified through a non-systematic literature search and no formal systematic-review or quantitative synthesis methodology was applied; findings should therefore be interpreted in this context. Institutional review board approval and informed consent were not required for this review of previously published literature.
Results
Multifocality occurs in 20-36% of papillary thyroid carcinomas and may arise from independent multicentric tumorigenesis or intrathyroidal clonal spread. Observational evidence has associated multifocality with an increased risk of recurrence in some, though not all, studies, particularly when combined with tumor size ≥6 mm, nodal involvement, or aggressive histologic variants; its independent effect on disease-specific mortality is less certain. Although AS is endorsed for selected low-risk PTMC, eligibility criteria vary internationally, especially for multifocal disease. The extent of surgery remains individualized.
Conclusion
PTMC management should follow a risk-adapted strategy that integrates tumor focality, pathological features and patient factors to avoid overtreatment and undertreatment.
Zitieren
APA
Al-Olayan, H. A. (2026). Individualized Management of Papillary Thyroid Microcarcinoma: Clinicopathological Risk Factors, Multifocality and Active Surveillance. Journal of Pioneering Medical Sciences, 15(6), 132-137. https://doi.org/10.47310/jpms2026150617
Vancouver
Al-Olayan HA. Individualized Management of Papillary Thyroid Microcarcinoma: Clinicopathological Risk Factors, Multifocality and Active Surveillance. Journal of Pioneering Medical Sciences. 2026;15(6):132-137. doi:10.47310/jpms2026150617
BibTeX
@article{AlOlayan2026,
author = {Al-Olayan, Hayfa Abdullah},
title = {Individualized Management of Papillary Thyroid Microcarcinoma: Clinicopathological Risk Factors, Multifocality and Active Surveillance},
journal = {Journal of Pioneering Medical Sciences},
year = {2026},
volume = {15},
number = {6},
pages = {132--137},
doi = {10.47310/jpms2026150617}
}
EUVIMED